June 14, 2024   USA
Beyond Biotech podcast – Looking to cure Type 1 diabetes

In the latest episode of the Beyond Biotech Podcast Anders Essen-Möller, founder of Diamyd Medical, talks about the company’s approach to tackling diabetes.

Listen to the podcast here

Diamyd Medical’s antigen-specific immunomodulator aiming to preserves insulin production is currently being evaluated in a confirmatory phase 3 trial.

Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research